Last Updated : March 22, 2019
Details
Generic Name:
cyclosporine
Project Status:
Withdrawn
Therapeutic Area:
keratitis, severe
Manufacturer:
Santen Canada Incorporated
Call for patient/clinician input open:
Brand Name:
Ikervis
Project Line:
Reimbursement Review
Project Number:
SR0518-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
keratitis, severe
Key Milestones2 | |
|---|---|
| Call for patient input posted | April 17, 2017 |
| Patient group input closed | June 06, 2017 |
| Clarification: - Patient input submission received | |
| Patient input summary sent for review to patient input groups | June 26, 2017 |
| Patient group comments on input summary closed | July 04, 2017 |
| Clarification: - Patient input summary feedback received | |
| Submission received | May 15, 2017 |
| Submission accepted for review | May 30, 2017 |
| Review initiated | May 31, 2017 |
| Clarification: - Voluntarily withdrawn by the manufacturer on 2017-July-11 | |
Last Updated : March 22, 2019